By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arpida Ltd. 

Dammstrasse 36

Munchenstein    4142  Switzerland
Phone: 41-61-417-9660 Fax: 41-61-417-9661



Company News
Evolva SA Agrees to Reverse Merger with Arpida 9/11/2009 8:43:50 AM
Arpida to Discuss Strategy With Shareholders 5/7/2009 11:48:23 AM
Arpida Annual General Meeting of Shareholders Approves All Board Proposals 5/7/2009 11:16:34 AM
Arpida Board Reviews Strategic Options to Present to Shareholders at Shareholders' Meeting 3/17/2009 10:33:06 AM
Arpida Announces Full Year 2008 Financial Results 2/25/2009 11:26:00 AM
FDA Issues Arpida Complete Response Letter for Iclaprim 1/20/2009 8:30:25 AM
Arpida Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on iclaprim 11/18/2008 10:06:28 AM
Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 10/27/2008 10:33:35 AM
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 10/15/2008 11:48:58 AM
Arpida Completes Enrollment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 9/24/2008 11:21:43 AM